Loss of p19^Arf Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms

• Danielle B. Ulanet,

  Current address: Agios Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  Affiliation Diabetes Center, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Douglas Hanahan

  * E-mail: dh@epfl.ch

  Current address: School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Swiss Institute for Experimental Cancer Research (ISREC), Lausanne, Switzerland

  Affiliations Diabetes Center, University of California San Francisco, San Francisco, California, United States of America, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, United States of America, Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, United States of America

  ⨯